Concepedia

Aneliya Parvanova

AP

21

Publications

1.7K

Citations

19

H-Index

2004

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Azienda Ospedaliera Treviglio

Istituti di Ricovero e Cura a Carattere Scientifico

Ospedale Papa Giovanni XXIII

Azienda Ospedaliero Universitaria Ospedali Riuniti

Aneliya Parvanova is an author at Mario Negri Institute for Pharmacological Research specializing in diabetes, medicine, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2004–2023

21

Publications

21

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

Piero Ruggenenti, Esteban Porrini, Flavio Gaspari et al. · Diabetes Care · 2012 · 313 citations · Full text

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 247 citations · Full text

, , +8

Insulin Resistance and Microalbuminuria

Aneliya Parvanova, Roberto Trevisan, Ilian Iliev et al. · Diabetes · 2006 · 196 citations · Full text

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

Flavio Gaspari, Piero Ruggenenti, Esteban Porrini et al. · Kidney International · 2013 · 148 citations

, , +9

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

Piero Ruggenenti, Giuseppe Lauria, Ilian Iliev et al. · Hypertension · 2011 · 98 citations · Full text

, , +21

Rows per page

1–5 of 21